Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer [Phase 2]
A Phase II randomized, open-label study in Taiwan compares GASL (gemcitabine + nab-paclitaxel with S-1/LV) versus GAP (gemcitabine + oxalipl…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers [Phase 1, Phase 2]
A Phase 1/2 feasibility trial evaluating the LUM Imaging System for detection of colorectal, pancreatic, esophageal, and gastric cancers is …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating glipizide to treat high blood sugar in people with pancreatic cancer; the study is…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase Ib/II clinical trial is evaluating the safety and efficacy of IBI363 in combination with chemotherapy as second-line therapy for unr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating zimberelimab and quemliclustat with chemotherapy for borderline resectable or locally advanced pancreati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Pancreatic Cancer Evolution Upon Treatment [NA]
A pancreatic cancer clinical trial exploring tumor evolution during treatment is currently recruiting. The sponsor is IRCCS San Raffaele.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
This clinical trial update describes the collection of tissue and blood from patients with benign and malignant tumors of the soft tissue an…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sample Collection for Ongoing Research and Product Evaluation Study
Natera reports an ongoing study update focused on sample collection for ongoing research and product evaluation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recrui…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]
A Phase 2 clinical trial evaluating DZ-002, a heptamine carboxymethine dye conjugate, as maintenance therapy for metastatic pancreatic cance…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: FAPi PET in Pancreatic Ductal Adenocarcinoma
A clinical trial is evaluating a fibroblast activation protein inhibitor (FAPi) PET imaging agent for pancreatic ductal adenocarcinoma and i…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
A recruiting clinical trial evaluating management options for malignant gastric outlet obstruction due to pancreatic cancer, comparing surgi…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy [NA]
This entry notes that the HistoSonics Edison System is being studied for pancreatic adenocarcinoma using histotripsy. The trial is currently…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Hepatobiliary and Pancreatic Tumor Biobank
Clinical trial update describing a hepatobiliary and pancreatic tumor biobank study led by Zhejiang University, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 NeoOPTIMIZE trial evaluating upfront switching between mFOLFIRINOX and Gemcitabine/Nab-Paclitaxel before surgery for resectable to u…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS)
A post-marketing surveillance study for olaparib (LYNPARZA) in pancreatic cancer in Japan has completed.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on the Phase 1/Phase 2 safety and efficacy study of NUV-1511 in adults with advanced solid tumors, including HER2-nega…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and preliminary efficacy of intravenous OMO-103, a Myc inhibitor, in patients with me…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HRS-4642 in combination with other antitumor therapies for locally advanced or metastatic pancreatic c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer [NA]
An update on a clinical trial evaluating computed tomography to aid diagnosis in patients with pancreatic or hepatobiliary cancers. The stud…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]
An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer [Phase 1]
First-in-human phase 1 study of TORL-2-307-ADC in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastro…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]
Seagen is conducting a Phase 1 study of SGN-MesoC2 in advanced solid tumors, including non-small cell lung cancer, ovarian cancer, pancreati…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nivolumab and ipilimumab with radiation therapy in microsatellite-stable and MSI-high colorectal cancer and pancrea…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Seven Trial: Exploiting the Unfolded Protein Response [Phase 1]
A Phase 1 clinical trial called The Seven Trial is exploring exploitation of the unfolded protein response in metastatic pancreatic cancer, …